Of interest, the low expression of CXCR4 as well as the class-A1 Rhodopsin-like receptors in COVID-derived CD4+ naïve T cells resulted in a reduced responsiveness of the IL-10 signaling pathway (Figure 3C), which may contribute to immunodeficiency in patients [37]. Here, CXCR4 is linked to immunodeficiency disease.